{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:38:57Z","timestamp":1787240337350,"version":"build-2736575974"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"United Kingdom\u2019s Department of Health NIHR University College London Hospitals Biomedical Research Centres funding scheme"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Lower urinary tract symptoms (LUTS) may precede or accompany the other symptoms of neurologic disease and may be the presenting clinical manifestations of central, peripheral, or autonomic nervous system dysfunction. In clinical practice, urologists are often the first specialists to evaluate these patients, potentially before underlying neurologic disease has been identified. Early recognition of neurologic contributors to LUTS may help prevent diagnostic delay. This review aims to provide a symptom-based framework that highlights common urologic presentations associated with underlying neurologic disease, along with urodynamic findings of concern, to support earlier recognition of neurological disease in patients presenting with LUTS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Recent work has characterized neurologic diseases associated with LUT dysfunction using disease-based frameworks. Despite this, gaps persist in routine urologic evaluation, including inconsistent screening for neurological symptoms and limited incorporation of focused neurologic history and examination. Certain urodynamic patterns are increasingly recognized as suggestive of neurological pathology but are not consistently interpreted within this context. Barriers to timely neurologic evaluation, including limited specialist availability and prolonged wait times, further contribute to diagnostic delay. As a result, there is growing recognition of the need for urologists to identify clinical features within LUTS presentation that should prompt consideration of neurologic disease, though practical strategies for integrating these insights into routine care remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>A symptom-based framework for evaluating LUTS can enhance early detection of neurologic disease in urologic practice. Urologists and pelvic health specialists should have a broad understanding of what clinical characteristics associated with LUTS should trigger concern for underlying neurological disease and should always consider neurological disease in the differential diagnosis. This review provides a practical, clinically oriented overview of neurologic disease in LUTS assessment, including guidance on screening questions, initial testing considerations, urodynamic interpretation, and referral, particularly in the settings with limited neurology access. Algorithms are provided to facilitate early recognition of occult neurological disease within routine urologic practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11934-026-01343-2","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:17:29Z","timestamp":1780391849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lower Urinary Tract Symptoms as an Indicator of Occult Neurologic Disease: A System-first Framework for Urologic Practice"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3219-2225","authenticated-orcid":false,"given":"Elizabeth","family":"Minnerath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6177-7604","authenticated-orcid":false,"given":"Olga","family":"Khazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5190-3259","authenticated-orcid":false,"given":"Jalesh N.","family":"Panicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6230-2552","authenticated-orcid":false,"given":"Marcus J.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0730-9038","authenticated-orcid":false,"given":"Elise J. B.","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"2","key":"1343_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41391-022-00610-w","volume":"26","author":"J Huang","year":"2023","unstructured":"Huang J, Chan CK, Yee S, Deng Y, Bai Y, Chan SC, et al. Global burden and temporal trends of lower urinary tract symptoms: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2023;26(2):421\u20138.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1343_CR2","doi-asserted-by":"crossref","unstructured":"Mattos RC, Favorito LA. Neurophysiology of Micturition: a Narrative Review on Preventing Mismanagement. Int Braz J Urol. 2025;51(3):e20259907.","DOI":"10.1590\/s1677-5538.ibju.2025.9907"},{"issue":"7","key":"1343_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1474-4422(15)00070-8","volume":"14","author":"JN Panicker","year":"2015","unstructured":"Panicker JN, Fowler CJ, Kessler TM. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol. 2015;14(7):720\u201332.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1343_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/j.2040-4603.2015.tb00596.x","volume":"5","author":"WC de Groat","year":"2015","unstructured":"de Groat WC, Griffiths D, Yoshimura N. Neural control of the lower urinary tract. Compr Physiol. 2015;5(1):327\u201396.","journal-title":"Compr Physiol"},{"issue":"3","key":"1343_CR5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/nau.70028","volume":"44","author":"MJ Drake","year":"2025","unstructured":"Drake MJ, Arlandis S, Averbeck MA, Agr\u00f2 EF, Hentzen C, Mosiello G, et al. Can We Improve Our Routine Urological Assessment to Exclude Neurogenic Causes for Lower Urinary Tract Dysfunction? ICI-RS 2024. Neurourol Urodyn. 2025;44(3):609\u201315.","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"1343_CR6","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1002\/nau.24469","volume":"39","author":"HA Roy","year":"2020","unstructured":"Roy HA, Nettleton J, Blain C, Dalton C, Farhan B, Fernandes A, et al. Assessment of patients with lower urinary tract symptoms where an undiagnosed neurological disease is suspected: A report from an International Continence Society consensus working group. Neurourol Urodyn. 2020;39(8):2535\u201343.","journal-title":"Neurourol Urodyn"},{"key":"1343_CR7","doi-asserted-by":"publisher","first-page":"103341","DOI":"10.1016\/j.autneu.2025.103341","volume":"262","author":"E Vichayanrat","year":"2025","unstructured":"Vichayanrat E, Koay S, Hentzen C, Wright S, Batla A, Simeoni S, et al. Lower urinary tract dysfunction reported in autonomic disorders. Auton Neurosci. 2025;262:103341.","journal-title":"Auton Neurosci"},{"issue":"4","key":"1343_CR8","doi-asserted-by":"publisher","first-page":"e70119","DOI":"10.1111\/ene.70119","volume":"32","author":"JN Panicker","year":"2025","unstructured":"Panicker JN, Fanciulli A, Skoric MK, Kaplan T, Aleksovska K, Adamec I, et al. European Academy of Neurology (EAN)\/European Federation of Autonomic Societies (EFAS)\/International Neuro-Urology Society (INUS) Guidelines for Practising Neurologists on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms (NEUROGED Guidelines). Eur J Neurol. 2025;32(4):e70119.","journal-title":"Eur J Neurol"},{"issue":"1","key":"1343_CR9","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/nau.24858","volume":"41","author":"S Mozafarpour","year":"2022","unstructured":"Mozafarpour S, Chen A, Paredes Mogica JA, Nwaoha N, Farhad K, Morrison SM, et al. Urodynamic autonomic bladder dysfunction in women with complex chronic pelvic pain is associated with small fiber polyneuropathy. Neurourol Urodyn. 2022;41(1):482\u20139.","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"1343_CR10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.2020.26858","volume":"325","author":"MP McGinley","year":"2021","unstructured":"McGinley MP, Goldschmidt CH, Rae-Grant AD. Diagnosis and Treatment of Multiple Sclerosis: A Review. JAMA. 2021;325(8):765\u201379.","journal-title":"JAMA"},{"issue":"7","key":"1343_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1177\/1352458515572406","volume":"21","author":"L Pandit","year":"2015","unstructured":"Pandit L, Asgari N, Apiwattanakul M, Palace J, Paul F, Leite MI, et al. Demographic and clinical features of neuromyelitis optica: A review. Mult Scler. 2015;21(7):845\u201353.","journal-title":"Mult Scler"},{"key":"1343_CR12","doi-asserted-by":"publisher","first-page":"966428","DOI":"10.3389\/fneur.2022.966428","volume":"13","author":"G Delgado-Garcia","year":"2022","unstructured":"Delgado-Garcia G, Lapidus S, Talero R, Levy M. The patient journey with NMOSD: From initial diagnosis to chronic condition. Front Neurol. 2022;13:966428.","journal-title":"Front Neurol"},{"key":"1343_CR13","doi-asserted-by":"publisher","first-page":"1260358","DOI":"10.3389\/fneur.2023.1260358","volume":"14","author":"JY Hor","year":"2023","unstructured":"Hor JY, Fujihara K. Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide. Front Neurol. 2023;14:1260358.","journal-title":"Front Neurol"},{"issue":"8","key":"1343_CR14","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1007\/s00415-011-6384-3","volume":"259","author":"A Uzawa","year":"2012","unstructured":"Uzawa A, Mori M, Muto M, Masuda S, Kuwabara S. When is neuromyelitis optica diagnosed after disease onset? J Neurol. 2012;259(8):1600\u20135.","journal-title":"J Neurol"},{"issue":"6","key":"1343_CR15","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1177\/13524585211039753","volume":"28","author":"SJ Blaschke","year":"2022","unstructured":"Blaschke SJ, Ellenberger D, Flachenecker P, Hellwig K, Paul F, P\u00f6hlau D, et al. Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry. Mult Scler. 2022;28(6):865\u201371.","journal-title":"Mult Scler"},{"issue":"1\u20132","key":"1343_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5489\/cuaj.4058","volume":"11","author":"SM Aharony","year":"2017","unstructured":"Aharony SM, Lam O, Corcos J. Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines. Can Urol Assoc J. 2017;11(1\u20132):61\u20134.","journal-title":"Can Urol Assoc J"},{"issue":"2","key":"1343_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1179\/2045772315Y.0000000021","volume":"39","author":"Y Akko\u00e7","year":"2016","unstructured":"Akko\u00e7 Y, Ers\u00f6z M, Y\u00fcceyar N, Tun\u00e7 H, K\u00f6kl\u00fc K, Yolda\u015f TK, et al. Overactive bladder symptoms in patients with multiple sclerosis: Frequency, severity, diagnosis and treatment. J Spinal Cord Med. 2016;39(2):229\u201333.","journal-title":"J Spinal Cord Med"},{"issue":"10","key":"1343_CR18","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.jocn.2008.12.012","volume":"16","author":"GF Nakipoglu","year":"2009","unstructured":"Nakipoglu GF, Kaya AZ, Orhan G, Tezen O, Tunc H, Ozgirgin N, et al. Urinary dysfunction in multiple sclerosis. J Clin Neurosci. 2009;16(10):1321\u20134.","journal-title":"J Clin Neurosci"},{"issue":"7","key":"1343_CR19","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1177\/1352458506075651","volume":"13","author":"M de S\u00e8ze","year":"2007","unstructured":"de S\u00e8ze M, Ruffion A, Denys P, Joseph P-A, Perrouin-Verbe B, null n. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Multiple Scler J. 2007;13(7):915\u201328.","journal-title":"Multiple Scler J"},{"issue":"4","key":"1343_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/ene.12370","volume":"21","author":"M Di Filippo","year":"2014","unstructured":"Di Filippo M, Proietti S, Gaetani L, Gubbiotti M, Di Gregorio M, Eusebi P, et al. Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis. Eur J Neurol. 2014;21(4):648\u201353.","journal-title":"Eur J Neurol"},{"key":"1343_CR21","doi-asserted-by":"publisher","first-page":"376023","DOI":"10.5402\/2012\/376023","volume":"2012","author":"S Nusrat","year":"2012","unstructured":"Nusrat S, Gulick E, Levinthal D, Bielefeldt K. Anorectal dysfunction in multiple sclerosis: a systematic review. ISRN Neurol. 2012;2012:376023.","journal-title":"ISRN Neurol"},{"key":"1343_CR22","unstructured":"Shumway CL, Patel BC, Tripathy K, De Jesus O. Neuromyelitis Optica Spectrum Disorder (NMOSD). StatPearls. Treasure Island (FL)2025."},{"issue":"2","key":"1343_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-0040-1701557","volume":"11","author":"A Gupta","year":"2020","unstructured":"Gupta A, Sivaram A, Krishnan R, Khanna M. Urinary Symptoms and Bladder Dysfunction in Patients with Neuromyelitis Optica Spectrum Disorders: Evaluation with Urodynamics and Management. J Neurosci Rural Pract. 2020;11(2):245\u20139.","journal-title":"J Neurosci Rural Pract"},{"issue":"1","key":"1343_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/nau.22667","volume":"35","author":"FL de Carvalho","year":"2016","unstructured":"de Carvalho FL, Gomes CM, Apostolos-Pereira SL, Bessa J Jr., Pinheiro M, Marchiori PE, et al. Voiding dysfunction in patients with neuromyelitis optica spectrum disorders. Neurourol Urodyn. 2016;35(1):39\u201343.","journal-title":"Neurourol Urodyn"},{"key":"1343_CR25","doi-asserted-by":"publisher","first-page":"850743","DOI":"10.3389\/fnagi.2022.850743","volume":"14","author":"Y Li","year":"2022","unstructured":"Li Y, Liu X, Wang J, Pan C, Tang Z. Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD). Front Aging Neurosci. 2022;14:850743.","journal-title":"Front Aging Neurosci"},{"issue":"21","key":"1343_CR26","doi-asserted-by":"publisher","first-page":"e2924","DOI":"10.1212\/WNL.0000000000011030","volume":"95","author":"V Li","year":"2020","unstructured":"Li V, Malladi P, Simeoni S, Pakzad M, Everett R, Satukijchai C, et al. A clinico-neurophysiological study of urogenital dysfunction in MOG-antibody transverse myelitis. Neurology. 2020;95(21):e2924\u201334.","journal-title":"Neurology"},{"issue":"12","key":"1343_CR27","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140(12):3128\u201338.","journal-title":"Brain"},{"issue":"2","key":"1343_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0090-4295(00)01070-0","volume":"57","author":"SJ Ciancio","year":"2001","unstructured":"Ciancio SJ, Mutchnik SE, Rivera VM, Boone TB. Urodynamic pattern changes in multiple sclerosis. Urology. 2001;57(2):239\u201345.","journal-title":"Urology"},{"key":"1343_CR29","doi-asserted-by":"publisher","first-page":"977572","DOI":"10.3389\/fnagi.2022.977572","volume":"14","author":"FF Li","year":"2022","unstructured":"Li FF, Cui YS, Yan R, Cao SS, Feng T. Prevalence of lower urinary tract symptoms, urinary incontinence and retention in Parkinson\u2019s disease: A systematic review and meta-analysis. Front Aging Neurosci. 2022;14:977572.","journal-title":"Front Aging Neurosci"},{"key":"1343_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.parkreldis.2016.10.024","volume":"35","author":"C McDonald","year":"2017","unstructured":"McDonald C, Winge K, Burn DJ. Lower urinary tract symptoms in Parkinson\u2019s disease: Prevalence, aetiology and management. Parkinsonism Relat Disord. 2017;35:8\u201316.","journal-title":"Parkinsonism Relat Disord"},{"key":"1343_CR31","first-page":"924605","volume":"2011","author":"R Sakakibara","year":"2011","unstructured":"Sakakibara R, Kishi M, Ogawa E, Tateno F, Uchiyama T, Yamamoto T, et al. Bladder, bowel, and sexual dysfunction in Parkinson\u2019s disease. Parkinsons Dis. 2011;2011:924605.","journal-title":"Parkinsons Dis"},{"issue":"16","key":"1343_CR32","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1503\/cmaj.151179","volume":"188","author":"P Rizek","year":"2016","unstructured":"Rizek P, Kumar N, Jog MS. An update on the diagnosis and treatment of Parkinson disease. CMAJ. 2016;188(16):1157\u201365.","journal-title":"CMAJ"},{"issue":"3","key":"1343_CR33","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3233\/JPD-213103","volume":"12","author":"E Hogg","year":"2022","unstructured":"Hogg E, Frank S, Oft J, Benway B, Rashid MH, Lahiri S. Urinary Tract Infection in Parkinson\u2019s Disease. J Parkinsons Dis. 2022;12(3):743\u201357.","journal-title":"J Parkinsons Dis"},{"issue":"10","key":"1343_CR34","doi-asserted-by":"publisher","first-page":"e946","DOI":"10.1212\/WNL.0000000000008053","volume":"93","author":"JH Shin","year":"2019","unstructured":"Shin JH, Park KW, Heo KO, Chung SJ, Choo M-S. Urodynamic study for distinguishing multiple system atrophy from Parkinson disease. Neurology. 2019;93(10):e946\u201353.","journal-title":"Neurology"},{"issue":"4","key":"1343_CR35","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.urols.2012.10.006","volume":"23","author":"C-H Kuei","year":"2012","unstructured":"Kuei C-H, Liao C-H, Kuo H-C. Urodynamic characteristics of lower urinary tract dysfunction in patients with Parkinson\u2019s disease. Urol Sci. 2012;23(4):120\u20133.","journal-title":"Urol Sci"},{"issue":"1","key":"1343_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/nau.24806","volume":"41","author":"CH Chiang","year":"2022","unstructured":"Chiang CH, Chen SF, Kuo HC. Video-urodynamic characteristics of lower urinary tract dysfunctions in patients with chronic brain disorders. Neurourol Urodyn. 2022;41(1):255\u201363.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"1343_CR37","first-page":"31","volume":"5","author":"BA Allio","year":"2016","unstructured":"Allio BA, Peterson AC. Urodynamic and physiologic patterns associated with the common causes of neurogenic bladder in adults. Transl Androl Urol. 2016;5(1):31\u20138.","journal-title":"Transl Androl Urol"},{"issue":"5","key":"1343_CR38","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.neurol.2023.11.013","volume":"180","author":"S Kaplan","year":"2024","unstructured":"Kaplan S. Prevalence of multiple system atrophy: A literature review. Rev Neurol. 2024;180(5):438\u201350.","journal-title":"Rev Neurol"},{"issue":"10","key":"1343_CR39","doi-asserted-by":"publisher","first-page":"6647","DOI":"10.1007\/s00415-024-12561-4","volume":"271","author":"ME Erro","year":"2024","unstructured":"Erro ME, Arrondo P, Gast\u00f3n I, Clavero P, de Gordoa JSR, Mart\u00ed Andr\u00e9s G, et al. Epidemiologic and clinical features of multisystem atrophy: a population-based study in Navarre, Spain. J Neurol. 2024;271(10):6647\u201354.","journal-title":"J Neurol"},{"issue":"3","key":"1343_CR40","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00415-019-09597-2","volume":"267","author":"JN Panicker","year":"2020","unstructured":"Panicker JN, Simeoni S, Miki Y, Batla A, Iodice V, Holton JL, et al. Early presentation of urinary retention in multiple system atrophy: can the disease begin in the sacral spinal cord? J Neurol. 2020;267(3):659\u201364.","journal-title":"J Neurol"},{"issue":"6","key":"1343_CR41","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10286-018-0550-y","volume":"29","author":"R Sakakibara","year":"2019","unstructured":"Sakakibara R, Panicker J, Simeoni S, Uchiyama T, Yamamoto T, Tateno F, et al. Bladder dysfunction as the initial presentation of multiple system atrophy: a prospective cohort study. Clin Auton Res. 2019;29(6):627\u201331.","journal-title":"Clin Auton Res"},{"issue":"1","key":"1343_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12883-023-03131-8","volume":"23","author":"W Hu","year":"2023","unstructured":"Hu W, Cheng Y, Pan J, Wang X, Li S, Fan Z, et al. Value of electrophysiological indicators in differential diagnosis of parkinson\u2019s disease and multiple system atrophy. BMC Neurol. 2023;23(1):94.","journal-title":"BMC Neurol"},{"issue":"7","key":"1343_CR43","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/mds.22332","volume":"24","author":"T Yamamoto","year":"2009","unstructured":"Yamamoto T, Sakakibara R, Uchiyama T, Liu Z, Ito T, Awa Y, et al. Questionnaire-based assessment of pelvic organ dysfunction in multiple system atrophy. Mov Disord. 2009;24(7):972\u20138.","journal-title":"Mov Disord"},{"issue":"17supplement2","key":"1343_CR44","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1212\/WNL.0000000000203785","volume":"100","author":"J Iregui","year":"2023","unstructured":"Iregui J, Wynn A, Hay K, Wong C, Stamler D. claassen d. Urinary Symptom Profile in Early Multiple System Atrophy (P9-9.002). Neurology. 2023;100(17supplement2):4152.","journal-title":"Neurology"},{"issue":"5","key":"1343_CR45","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/S0022-5347(17)35246-1","volume":"151","author":"RO Beck","year":"1994","unstructured":"Beck RO, Betts CD, Fowler CJ. Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. J Urol. 1994;151(5):1336\u201341.","journal-title":"J Urol"},{"issue":"5","key":"1343_CR46","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/jnnp.71.5.600","volume":"71","author":"R Sakakibara","year":"2001","unstructured":"Sakakibara R, Hattori T, Uchiyama T, Yamanishi T. Videourodynamic and sphincter motor unit potential analyses in Parkinson\u2019s disease and multiple system atrophy. J Neurol Neurosurg Psychiatry. 2001;71(5):600\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"1343_CR47","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/mdc3.13307","volume":"8","author":"S Eschlbock","year":"2021","unstructured":"Eschlbock S, Kiss G, Krismer F, Fanciulli A, Kaindlstorfer C, Raccagni C, et al. Urodynamic Evaluation in Multiple System Atrophy: A Retrospective Cohort Study. Mov Disord Clin Pract. 2021;8(7):1052\u201360.","journal-title":"Mov Disord Clin Pract"},{"issue":"1","key":"1343_CR48","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.12786\/bn.2023.16.e7","volume":"16","author":"W Choi","year":"2023","unstructured":"Choi W, Cha KH, Park H, Huh S, Ko SH, Shin YI, et al. Urodynamic Study in Multiple System Atrophy: A Retrospective Observational Study. Brain Neurorehabil. 2023;16(1):e7.","journal-title":"Brain Neurorehabil"},{"key":"1343_CR49","doi-asserted-by":"publisher","first-page":"100022","DOI":"10.1016\/j.cont.2022.100022","volume":"1","author":"B Welk","year":"2022","unstructured":"Welk B, Sakakibara R, Sinha S, Haslam C, Vrijens D, Gomes C, et al. Lower urinary tract dysfunction in uncommon neurological diseases: A report of the neurourology promotion committee of the International Continence Society. Continence. 2022;1:100022.","journal-title":"Continence"},{"key":"1343_CR50","doi-asserted-by":"publisher","first-page":"1024995","DOI":"10.3389\/fneur.2022.1024995","volume":"13","author":"M Fei","year":"2022","unstructured":"Fei M, Wang F, Wu H, Liu S, Gan J, Ji Y. Characteristics of initial symptoms in patients with dementia with Lewy body disease. Front Neurol. 2022;13:1024995.","journal-title":"Front Neurol"},{"issue":"3","key":"1343_CR51","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/mds.25985","volume":"30","author":"F Tateno","year":"2015","unstructured":"Tateno F, Sakakibara R, Ogata T, Kishi M, Tsuyusaki Y, Takahashi O, et al. Lower urinary tract function in dementia with Lewy bodies (DLB). Mov Disord. 2015;30(3):411\u20135.","journal-title":"Mov Disord"},{"issue":"4","key":"1343_CR52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1212\/01.wnl.0000296826.61499.26","volume":"70","author":"GN Ransmayr","year":"2008","unstructured":"Ransmayr GN, Holliger S, Schletterer K, Heidler H, Deibl M, Poewe W, et al. Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease. Neurology. 2008;70(4):299\u2013303.","journal-title":"Neurology"},{"key":"1343_CR53","unstructured":"Sanders AE, Schoo C, Kalish VB. Vascular Dementia. StatPearls. Treasure Island (FL)2026."},{"issue":"2","key":"1343_CR54","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.4081\/ni.2012.e13","volume":"4","author":"R Sakakibara","year":"2012","unstructured":"Sakakibara R, Panicker J, Fowler CJ, Tateno F, Kishi M, Tsuyuzaki Y, et al. Vascular incontinence: incontinence in the elderly due to ischemic white matter changes. Neurol Int. 2012;4(2):e13.","journal-title":"Neurol Int"},{"key":"1343_CR55","doi-asserted-by":"publisher","first-page":"1017449","DOI":"10.3389\/fnagi.2022.1017449","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao P, Zhang G, Shen Y, Wang Y, Shi L, Wang Z, et al. Urinary dysfunction in patients with vascular cognitive impairment. Front Aging Neurosci. 2022;14:1017449.","journal-title":"Front Aging Neurosci"},{"issue":"6 Pt 1","key":"1343_CR56","first-page":"2086","volume":"165","author":"G Bratslavsky","year":"2001","unstructured":"Bratslavsky G, Kogan B, Levin RM. Urethra is more sensitive to ischemia than bladder: evidence from an in vitro rat study. J Urol. 2001;165(6 Pt 1):2086\u201390.","journal-title":"J Urol"},{"issue":"22","key":"1343_CR57","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMra2306506","volume":"393","author":"MD Johnson","year":"2025","unstructured":"Johnson MD, Williams MA. Idiopathic Normal-Pressure Hydrocephalus. N Engl J Med. 2025;393(22):2243\u201353.","journal-title":"N Engl J Med"},{"issue":"4","key":"1343_CR58","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1002\/nau.23084","volume":"36","author":"SC Krzastek","year":"2017","unstructured":"Krzastek SC, Bruch WM, Robinson SP, Young HF, Klausner AP. Characterization of lower urinary tract symptoms in patients with idiopathic normal pressure hydrocephalus. Neurourol Urodyn. 2017;36(4):1167\u201373.","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"1343_CR59","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/nau.20547","volume":"27","author":"R Sakakibara","year":"2008","unstructured":"Sakakibara R, Kanda T, Sekido T, Uchiyama T, Awa Y, Ito T, et al. Mechanism of bladder dysfunction in idiopathic normal pressure hydrocephalus. Neurourol Urodyn. 2008;27(6):507\u201310.","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"1343_CR60","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/nau.22600","volume":"34","author":"F Campos-Juanatey","year":"2015","unstructured":"Campos-Juanatey F, Guti\u00e9rrez-Ba\u00f1os JL, Portillo-Mart\u00edn JA, Zubillaga-Guerrero S. Assessment of the urodynamic diagnosis in patients with urinary incontinence associated with normal pressure hydrocephalus. Neurourol Urodyn. 2015;34(5):465\u20138.","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"1343_CR61","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ana.24320","volume":"77","author":"EE Smith","year":"2015","unstructured":"Smith EE, O\u2019Donnell M, Dagenais G, Lear SA, Wielgosz A, Sharma M, et al. Early cerebral small vessel disease and brain volume, cognition, and gait. Ann Neurol. 2015;77(2):251\u201361.","journal-title":"Ann Neurol"},{"issue":"23","key":"1343_CR62","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1001\/jama.2010.1833","volume":"304","author":"P Suri","year":"2010","unstructured":"Suri P, Rainville J, Kalichman L, Katz JN. Does This Older Adult With Lower Extremity Pain Have the Clinical Syndrome of Lumbar Spinal Stenosis? JAMA. 2010;304(23):2628\u201336.","journal-title":"JAMA"},{"issue":"6","key":"1343_CR63","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1080\/00207454.2017.1400973","volume":"128","author":"J Gandhi","year":"2018","unstructured":"Gandhi J, Shah J, Joshi G, Vatsia S, DiMatteo A, Joshi G, et al. Neuro-urological sequelae of lumbar spinal stenosis. Int J Neurosci. 2018;128(6):554\u201362.","journal-title":"Int J Neurosci"},{"issue":"3","key":"1343_CR64","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/147323001003800344","volume":"38","author":"ML Cong","year":"2010","unstructured":"Cong ML, Gong WM, Zhang QG, Sun BW, Liu SH, Li L, et al. Urodynamic study of bladder function for patients with lumbar spinal stenosis treated by surgical decompression. J Int Med Res. 2010;38(3):1149\u201355.","journal-title":"J Int Med Res"},{"issue":"23","key":"1343_CR65","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMra2308055","volume":"390","author":"RM Friedlander","year":"2024","unstructured":"Friedlander RM. Congenital and Acquired Chiari Syndrome. N Engl J Med. 2024;390(23):2191\u20138.","journal-title":"N Engl J Med"},{"issue":"5","key":"1343_CR66","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1056\/NEJMra2116032","volume":"387","author":"BJ Iskandar","year":"2022","unstructured":"Iskandar BJ, Finnell RH. Spina Bifida. N Engl J Med. 2022;387(5):444\u201350.","journal-title":"N Engl J Med"},{"issue":"8","key":"1343_CR67","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S1474-4422(13)70110-8","volume":"12","author":"AJ Copp","year":"2013","unstructured":"Copp AJ, Stanier P, Greene ND. Neural tube defects: recent advances, unsolved questions, and controversies. Lancet Neurol. 2013;12(8):799\u2013810.","journal-title":"Lancet Neurol"},{"key":"1343_CR68","unstructured":"Patel NT, Rizk EB, Simon SD, Spina Bifida. American Association of Neurological Surgeons; 2024 [Available from: https:\/\/www.aans.org\/patients\/conditions-treatments\/spina-bifida\/"},{"issue":"4","key":"1343_CR69","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/nau.2150","volume":"22","author":"R Sakakibara","year":"2003","unstructured":"Sakakibara R, Hattori T, Uchiyama T, Kamura K, Yamanishi T. Uroneurological assessment of spina bifida cystica and occulta. Neurourol Urodyn. 2003;22(4):328\u201334.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"1343_CR70","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/neuros\/nyy586","volume":"86","author":"AI Yang","year":"2020","unstructured":"Yang AI, Rinehart CD, McShane BJ, Hitti FL, Welch WC. Growth of Lumbosacral Perineural (Tarlov) Cysts: A Natural History Analysis. Neurosurgery. 2020;86(1):88\u201392.","journal-title":"Neurosurgery"},{"issue":"3","key":"1343_CR71","first-page":"375","volume":"40","author":"JA Paredes Mogica","year":"2024","unstructured":"Paredes Mogica JA, Feigenbaum F, Pilitsis JG, Schrot RJ, Oaklander AL, De EJB. Sacral Tarlov perineurial cysts: a systematic review of treatment options. J Neurosurgery: Spine. 2024;40(3):375\u201388.","journal-title":"J Neurosurgery: Spine"},{"issue":"9","key":"1343_CR72","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1111\/ene.15869","volume":"30","author":"C Hentzen","year":"2023","unstructured":"Hentzen C, Cabrilo I, Malladi P, Simeoni S, Amarenco G, Zaidman N, et al. Sacral Tarlov cysts: Neurophysiology abnormalities and correlation with pelvic sensory and visceral symptoms. Eur J Neurol. 2023;30(9):2838\u201348.","journal-title":"Eur J Neurol"},{"issue":"1","key":"1343_CR73","doi-asserted-by":"publisher","first-page":"e16530","DOI":"10.1111\/ene.16530","volume":"32","author":"I Cabrilo","year":"2025","unstructured":"Cabrilo I, Hentzen C, Malladi P, Simeoni S, Amarenco G, Zaidman N, et al. Midline sacral meningeal cysts: Neurophysiology abnormalities and their correlation with pelvic sensory and visceral symptoms. Eur J Neurol. 2025;32(1):e16530.","journal-title":"Eur J Neurol"},{"issue":"2","key":"1343_CR74","doi-asserted-by":"publisher","first-page":"929","DOI":"10.21873\/anticanres.15552","volume":"42","author":"M Scampa","year":"2022","unstructured":"Scampa M, Tessitore E, Dominguez DE, Hannouche D, Buchs NC, Kalbermatten DF, et al. Sacral Chordoma: A Population-based Analysis of Epidemiology and Survival Outcomes. Anticancer Res. 2022;42(2):929\u201337.","journal-title":"Anticancer Res"},{"issue":"2","key":"1343_CR75","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/S1470-2045(14)71190-8","volume":"16","author":"S Stacchiotti","year":"2015","unstructured":"Stacchiotti S, Sommer J. Building a global consensus approach to chordoma: a position paper from the medical and patient community. Lancet Oncol. 2015;16(2):e71\u201383.","journal-title":"Lancet Oncol"},{"issue":"5","key":"1343_CR76","first-page":"667","volume":"22","author":"MJVA Bradshaw","year":"2016","unstructured":"Bradshaw MJVA. Herpes simplex virus\u20132 (HSV\u20132) myeloradiculitis: A diagnostic challenge. J Neurovirol. 2016;22(5):667\u201370.","journal-title":"J Neurovirol"},{"issue":"6","key":"1343_CR77","first-page":"543","volume":"17","author":"RHT Sakakibara","year":"1998","unstructured":"Sakakibara RHT, Yasuda K, Yamanishi T. Mictruitional Disturbance in herpes zoster. Neurourol Urodyn. 1998;17(6):543\u20138.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"1343_CR78","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/mus.20639","volume":"35","author":"R Sakakibara","year":"2007","unstructured":"Sakakibara R, Uchiyama T, Tamura N, Kuwabara S, Asahina M, Hattori T. Urinary retention and sympathetic sphincter obstruction in axonal Guillain-Barr\u00e9 syndrome. Muscle Nerve. 2007;35(1):111\u20135.","journal-title":"Muscle Nerve"},{"issue":"2","key":"1343_CR79","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJM199507133330203","volume":"333","author":"J Partanen","year":"1995","unstructured":"Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural History of Peripheral Neuropathy in Patients with Non-Insulin-Dependent Diabetes Mellitus. N Engl J Med. 1995;333(2):89\u201394.","journal-title":"N Engl J Med"},{"issue":"2","key":"1343_CR80","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/00005392-199502000-00013","volume":"153","author":"SA Kaplan","year":"1995","unstructured":"Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol. 1995;153(2):342\u20134.","journal-title":"J Urol"},{"key":"1343_CR81","doi-asserted-by":"crossref","unstructured":"Denis T, Pettijohn D, De E, Argoff CE. Undiagnosed neurologic disease in refractory chronic pelvic pain: High yield in screen-positive patients. Continence. 2025;14:101900.","DOI":"10.1016\/j.cont.2025.101900"},{"issue":"22","key":"1343_CR82","doi-asserted-by":"publisher","first-page":"e2236","DOI":"10.1212\/WNL.0000000000012894","volume":"97","author":"SA Johnson","year":"2021","unstructured":"Johnson SA, Shouman K, Shelly S, Sandroni P, Berini SE, Dyck PJB, et al. Small Fiber Neuropathy Incidence, Prevalence, Longitudinal Impairments, and Disability. Neurology. 2021;97(22):e2236\u201347.","journal-title":"Neurology"},{"issue":"3","key":"1343_CR83","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/mus.27340","volume":"64","author":"LM Bitzi","year":"2021","unstructured":"Bitzi LM, Lehnick D, Wilder-Smith EP. Small fiber neuropathy: Swiss cohort characterization. Muscle Nerve. 2021;64(3):293\u2013300.","journal-title":"Muscle Nerve"},{"issue":"22","key":"1343_CR84","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1212\/WNL.0000000000010988","volume":"95","author":"R Freeman","year":"2020","unstructured":"Freeman R, Gewandter JS, Faber CG, Gibbons C, Haroutounian S, Lauria G, et al. Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria. Neurology. 2020;95(22):1005\u201314.","journal-title":"Neurology"},{"issue":"12","key":"1343_CR85","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1093\/brain\/awz333","volume":"142","author":"G Devigili","year":"2019","unstructured":"Devigili G, Rinaldo S, Lombardi R, Cazzato D, Marchi M, Salvi E, et al. Diagnostic criteria for small fibre neuropathy in clinical practice and research. Brain. 2019;142(12):3728\u201336.","journal-title":"Brain"},{"issue":"3","key":"1343_CR86","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/pm\/pny001","volume":"20","author":"A Chen","year":"2019","unstructured":"Chen A, De E, Argoff C. Small Fiber Polyneuropathy Is Prevalent in Patients Experiencing Complex Chronic Pelvic Pain. Pain Med. 2019;20(3):521\u20137.","journal-title":"Pain Med"},{"key":"1343_CR87","doi-asserted-by":"publisher","first-page":"810809","DOI":"10.3389\/fpain.2021.810809","volume":"2","author":"DT Wolff","year":"2021","unstructured":"Wolff DT, Walker SJ. Small Fiber Polyneuropathy May Be a Nexus Between Autonomic Nervous System Dysregulation and Pain in Interstitial Cystitis\/Bladder Pain Syndrome. Front Pain Res (Lausanne). 2021;2:810809.","journal-title":"Front Pain Res (Lausanne)"},{"issue":"2","key":"1343_CR88","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.juro.2016.03.142","volume":"196","author":"G Chelimsky","year":"2016","unstructured":"Chelimsky G, Simpson P, McCabe N, Zhang L, Chelimsky T. Autonomic Testing in Women with Chronic Pelvic Pain. J Urol. 2016;196(2):429\u201334.","journal-title":"J Urol"},{"issue":"11","key":"1343_CR89","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00192-019-04011-x","volume":"30","author":"CA Matthews","year":"2019","unstructured":"Matthews CA, Deveshwar SP, Evans RJ, Badlani G, Walker SJ. Small fiber polyneuropathy as a potential therapeutic target in interstitial cystitis\/bladder pain syndrome. Int Urogynecol J. 2019;30(11):1817\u201320.","journal-title":"Int Urogynecol J"},{"key":"1343_CR90","doi-asserted-by":"crossref","unstructured":"Katzberg HD, So Y, Brannagan T, England J, Bromberg M, David W et al. Diagnostic and Screening Laboratory Tests in the Assessment of Patients With Small Fiber Neuropathy: An Evidence-Based Review-Report of the American Association of Neuromuscular and Electrodiagnostic Medicine Small Fiber Neuropathy Task Force. Muscle Nerve. 2026.","DOI":"10.1002\/mus.70119"},{"issue":"10","key":"1343_CR91","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jamaneurol.2019.2917","volume":"76","author":"AL Oaklander","year":"2019","unstructured":"Oaklander AL, Nolano M. Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy: A Review. JAMA Neurol. 2019;76(10):1240\u201351.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1343_CR92","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1055\/s-0044-1791823","volume":"45","author":"G Devigili","year":"2025","unstructured":"Devigili G, Lombardi R, Lauria G, Cazzato D. The Evolving Landscape of Small Fiber Neuropathy. Semin Neurol. 2025;45(1):132\u201344.","journal-title":"Semin Neurol"},{"key":"1343_CR93","doi-asserted-by":"publisher","first-page":"1679316","DOI":"10.3389\/fneur.2025.1679316","volume":"16","author":"JP Lefaucheur","year":"2025","unstructured":"Lefaucheur JP, Gendre T, S\u00e8ne D. A structured list of laboratory tests for screening the possible causes of small fiber neuropathy in clinical practice. Front Neurol. 2025;16:1679316.","journal-title":"Front Neurol"},{"issue":"12","key":"1343_CR94","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s11910-022-01240-4","volume":"22","author":"G Lamotte","year":"2022","unstructured":"Lamotte G, Sandroni P. Updates on the Diagnosis and Treatment of Peripheral Autonomic Neuropathies. Curr Neurol Neurosci Rep. 2022;22(12):823\u201337.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"12","key":"1343_CR95","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11910-019-1020-1","volume":"19","author":"K Farhad","year":"2019","unstructured":"Farhad K. Current Diagnosis and Treatment of Painful Small Fiber Neuropathy. Curr Neurol Neurosci Rep. 2019;19(12):103.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1343_CR96","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.urology.2021.02.028","volume":"153","author":"N Faure Walker","year":"2021","unstructured":"Faure Walker N, Gall R, Gall N, Feuer J, Harvey H, Taylor C. The Postural Tachycardia Syndrome (PoTS) Bladder\u2014Urodynamic Findings. Urology. 2021;153:107\u201312.","journal-title":"Urology"},{"issue":"1","key":"1343_CR97","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/mus.22178","volume":"45","author":"AZ Burakgazi","year":"2012","unstructured":"Burakgazi AZ, Alsowaity B, Burakgazi ZA, Unal D, Kelly JJ. Bladder dysfunction in peripheral neuropathies. Muscle Nerve. 2012;45(1):2\u20138.","journal-title":"Muscle Nerve"},{"issue":"12","key":"1343_CR98","doi-asserted-by":"publisher","first-page":"e16486","DOI":"10.1111\/ene.16486","volume":"31","author":"E Vichayanrat","year":"2024","unstructured":"Vichayanrat E, Hentzen C, Simeoni S, Pakzad M, Iodice V, Panicker JN. Pelvic autonomic dysfunction is common in patients with pure autonomic failure. Eur J Neurol. 2024;31(12):e16486.","journal-title":"Eur J Neurol"},{"issue":"6","key":"1343_CR99","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10286-021-00829-y","volume":"31","author":"DS Goldstein","year":"2021","unstructured":"Goldstein DS, Isonaka R, Lamotte G, Kaufmann H. Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies. Clin Auton Res. 2021;31(6):677\u201384.","journal-title":"Clin Auton Res"},{"issue":"7","key":"1343_CR100","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1093\/brain\/awae033","volume":"147","author":"P Millar Vernetti","year":"2024","unstructured":"Millar Vernetti P, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, Shibao CA, Peltier A, et al. Phenoconversion in pure autonomic failure: a multicentre prospective longitudinal cohort study. Brain. 2024;147(7):2440\u20138.","journal-title":"Brain"},{"issue":"7","key":"1343_CR101","doi-asserted-by":"publisher","first-page":"e889","DOI":"10.1212\/WNL.0000000000010002","volume":"95","author":"EA Coon","year":"2020","unstructured":"Coon EA, Mandrekar JN, Berini SE, Benarroch EE, Sandroni P, Low PA, et al. Predicting phenoconversion in pure autonomic failure. Neurology. 2020;95(7):e889\u201397.","journal-title":"Neurology"},{"issue":"4","key":"1343_CR102","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/joim.12895","volume":"286","author":"BH Shaw","year":"2019","unstructured":"Shaw BH, Stiles LE, Bourne K, Green EA, Shibao CA, Okamoto LE, et al. The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey. J Intern Med. 2019;286(4):438\u201348.","journal-title":"J Intern Med"},{"issue":"3","key":"1343_CR103","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/nau.22971","volume":"36","author":"MR Kaufman","year":"2017","unstructured":"Kaufman MR, Chang-Kit L, Raj SR, Black BK, Milam DF, Reynolds WS, et al. Overactive bladder and autonomic dysfunction: Lower urinary tract symptoms in females with postural tachycardia syndrome. Neurourol Urodyn. 2017;36(3):610\u20133.","journal-title":"Neurourol Urodyn"},{"issue":"12","key":"1343_CR104","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/S1474-4422(11)70245-9","volume":"10","author":"MJ Titulaer","year":"2011","unstructured":"Titulaer MJ, Lang B, Verschuuren JJ. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2011;10(12):1098\u2013107.","journal-title":"Lancet Neurol"},{"key":"1343_CR105","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jocn.2019.04.003","volume":"65","author":"Y Liu","year":"2019","unstructured":"Liu Y, Xi J, Zhou L, Wu H, Yue D, Zhu W, et al. Clinical characteristics and long term follow-up of Lambert-Eaton myasthenia syndrome in patients with and without small cell lung cancer. J Clin Neurosci. 2019;65:41\u20135.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"1343_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-510X(00)00460-3","volume":"183","author":"K Satoh","year":"2001","unstructured":"Satoh K, Motomura M, Suzu H, Nakao Y, Fujimoto T, Fukuda T, et al. Neurogenic bladder in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine. J Neurol Sci. 2001;183(1):1\u20134.","journal-title":"J Neurol Sci"},{"issue":"4","key":"1343_CR107","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ana.26018","volume":"89","author":"S Koay","year":"2021","unstructured":"Koay S, Vichayanrat E, Bremner F, Panicker JN, Lang B, Lunn MP, et al. Multimodal Biomarkers Quantify Recovery in Autoimmune Autonomic Ganglionopathy. Ann Neurol. 2021;89(4):753\u201368.","journal-title":"Ann Neurol"},{"issue":"2","key":"1343_CR108","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/mus.27532","volume":"66","author":"S Thomas","year":"2022","unstructured":"Thomas S, Conway KM, Fapo O, Street N, Mathews KD, Mann JR, et al. Time to diagnosis of Duchenne muscular dystrophy remains unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network, 2000\u20132015. Muscle Nerve. 2022;66(2):193\u20137.","journal-title":"Muscle Nerve"},{"issue":"1","key":"1343_CR109","doi-asserted-by":"publisher","first-page":"e1892","DOI":"10.1002\/jgc4.1892","volume":"34","author":"AM Pickart","year":"2025","unstructured":"Pickart AM, Martin AS, Gross BN, Dellefave-Castillo LM, McCallen LM, Nagaraj CB, et al. Genetic counseling for the dystrophinopathies-Practice resource of the National Society of Genetic Counselors. J Genet Couns. 2025;34(1):e1892.","journal-title":"J Genet Couns"},{"issue":"24","key":"1343_CR110","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1212\/WNL.0000000000012111","volume":"96","author":"JJ Majersik","year":"2021","unstructured":"Majersik JJ, Ahmed A, Chen IA, Shill H, Hanes GP, Pelak VS, et al. A Shortage of Neurologists - We Must Act Now: A Report From the AAN 2019 Transforming Leaders Program. Neurology. 2021;96(24):1122\u201334.","journal-title":"Neurology"},{"issue":"1","key":"1343_CR111","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","volume":"61","author":"P Abrams","year":"2003","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37\u201349.","journal-title":"Urology"},{"key":"1343_CR112","doi-asserted-by":"crossref","unstructured":"Perrin A, Corcos J. The Utility of Urodynamic Studies in Neuro-Urological Patients. Biomedicines. 2023;11(4):1134.","DOI":"10.3390\/biomedicines11041134"},{"key":"1343_CR113","doi-asserted-by":"crossref","unstructured":"Bushnell JY, Cates LN, Hyde JE, Hofstetter CP, Yang CC, Khaing ZZ. Early Detrusor Application of Botulinum Toxin A Results in Reduced Bladder Hypertrophy and Fibrosis after Spinal Cord Injury in a Rodent Model. Toxins (Basel). 2022;14(11):777.","DOI":"10.3390\/toxins14110777"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01343-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-026-01343-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01343-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:03:18Z","timestamp":1780434198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-026-01343-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1343"],"URL":"https:\/\/doi.org\/10.1007\/s11934-026-01343-2","relation":{},"ISSN":["1534-6285"],"issn-type":[{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JNP is supported in part by funding from the United Kingdom\u2019s Department of Health NIHR University College London Hospitals Biomedical Research Centres funding scheme.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MD is on speaker bureau and advisory boards for Astellas, Pierre Fabre, Nowwell, and Viatris.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ED is Chair DSMB NIDDK\/NIH Protocol Number: EPPIC22001, a consultant for Flume catheters and Luca Biologics, is on the advisory board for Ironwood Pharmaceuticals and Glycologix, was PI on a study for Ironwood pharmaceuticals, has stock in Doximity and ERYP, Shares in Restoration Medicine, Owner of Pelvic Answers LLC and runs\n                      \n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}